The ability of plasma proteomics studies to deliver useful protein biomarkers has remained lower than initial expectations, prompting a redefinition of the plasma biomarker development pipeline.
Download this article, compliments of Thermo Fisher Scientific, to learn more about a novel global plasma proteome quantification workflow.